United-Guardian, Inc.  

(Public, NASDAQ:UG)   Watch this stock  
Find more results for UG
25.79
+0.79 (3.16%)
May 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 24.90 - 25.97
52 week 16.75 - 25.97
Open 25.00
Vol / Avg. 5,832.00/3,859.00
Mkt cap 118.54M
P/E 22.94
Div/yield 0.47/5.16
EPS 1.12
Shares 4.60M
Beta 0.28
Inst. own 15%
Aug 5, 2013
Q2 2013 United-Guardian Inc Earnings Release Add to calendar
May 15, 2013
United-Guardian Inc Annual Shareholder Meeting
May 13, 2013
Q1 2013 United-Guardian Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 39.59% 34.94%
Operating margin 57.49% 47.86%
EBITD margin - 45.95%
Return on average assets 41.61% 33.18%
Return on average equity 46.05% 35.85%
Employees 30 -
Carbon Disclosure Rating - -

Address

230 Marcus Blvd., P.O. Box 18050
HAUPPAUGE, NY 11788
United States - Map
+1-631-2730900 (Phone)
+1-631-2730858 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

United-Guardian, Inc. (United), through its Guardian Laboratories Division (Guardian), manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical and health care products, and specialty industrial products. The Company also conducts research and development, primarily related to the development of cosmetic and personal care products. The Company�s products are into four product categories: pharmaceuticals, personal care products (including cosmetic ingredients), medical products, and industrial products. The Company�s two product lines are the LUBRAJEL line of cosmetic ingredients and medical lubricants, which accounted for approximately 82% of the Company's sales during the year ended December 31, 2011, and its RENACIDIN IRRIGATION (RENACIDIN), a pharmaceutical product that accounted for approximately 13% of its sales during 2011. The Company's products are marketed through collaborative agreements with larger companies.

Officers and directors

Kenneth H. Globus Chairman of the Board, President, General Counsel
Age: 60
Bio & Compensation  - Reuters
Robert S. Rubinger Chief Financial Officer, Executive Vice President, Treasurer, Secretary, Director
Age: 69
Bio & Compensation  - Reuters
Peter A. Hiltunen Vice President
Age: 53
Bio & Compensation  - Reuters
Joseph J. Vernice Vice President, Manager - Research and Development, Director - Technical Services
Age: 54
Bio & Compensation  - Reuters
Roseann LaCorte Controller
Age: 45
Bio & Compensation  - Reuters
Andrew A. Boccone Independent Director
Age: 66
Bio & Compensation  - Reuters
Arthur M. Dresner Independent Director
Age: 70
Bio & Compensation  - Reuters
Lawrence F. Maietta Independent Director
Age: 54
Bio & Compensation  - Reuters
Christopher W. Nolan Sr. Independent Director
Age: 47
Bio & Compensation  - Reuters